Cargando…
Initiative for Promoting Affordable and Quality Tuberculosis Tests (IPAQT): a market-shaping intervention in India
A majority of patients with tuberculosis (TB) in India are diagnosed and treated in the private sector. Yet, most private providers do not use most recent WHO-endorsed microbiological tests such as liquid cultures, line probe assays and Xpert MTB/RIF due to a combination of factors such as lack of a...
Autores principales: | Dabas, Harkesh, Deo, Sarang, Sabharwal, Manisha, Pal, Arnab, Salim, Sachin, Nair, Lakshmi, Chauhan, Kaartikeya, Maheshwari, Prateek, Parulkar, Aparna, Singh, Ritu, Chitalia, Manasi, Kadam, Rigveda, Kaur, Manjot, Oghor, Collins, Ponnudurai, Nirros, Kumta, Sameer, Small, Peter, Dewan, Puneet, Pai, Madhukar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936393/ https://www.ncbi.nlm.nih.gov/pubmed/31908854 http://dx.doi.org/10.1136/bmjgh-2019-001539 |
Ejemplares similares
-
Field sales force model to increase adoption of a novel tuberculosis diagnostic test among private providers: evidence from India
por: Deo, Sarang, et al.
Publicado: (2020) -
New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF
por: Ponnudurai, Nirros, et al.
Publicado: (2018) -
Predicting the impact of patient and private provider behavior on diagnostic delay for pulmonary tuberculosis patients in India: A simulation modeling study
por: Deo, Sarang, et al.
Publicado: (2020) -
Breast Implant-associated Anaplastic Large Cell Lymphoma: A Canadian Surgical Oncology Survey
por: Azzi, Alain J., et al.
Publicado: (2020) -
Testing and Treating the Missing Millions with Tuberculosis
por: Pai, Madhukar, et al.
Publicado: (2015)